Publication: Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia
Program
KU-Authors
KU Authors
Co-Authors
Şimşek, Eda Tanrıkulu
Eskazan, Ahmet Emre
Cengiz, Mahir
Ar, M. Cem
Ekizoğlu, Seda
Salihoğlu, Ayşe
Gültürk, Emine
Elverdi, Tuğrul
Aydın, Seniz Öngören
Demiröz, Ahu Senem
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
BAKILACAK
Source
Publisher
American Society Hematology
Subject
Hematology
Citation
Has Part
Source
Blood
Book Series Title
Edition
DOI
item.page.datauri
Link
Rights
N/A